Performance & Life Science Chemicals | Key figures |
[ XLS ] |
||
|
|
|
|
€ million |
2007 |
2006 |
Δ in % |
1,235 |
1,217 |
1.5 |
|
Gross margin |
615 |
613 |
0.4 |
58 |
67 |
–13 |
|
144 |
155 |
–7.0 |
|
– |
–34 |
– |
|
132 |
132 |
–0.5 |
|
Free cash flow adjusted for acquisitions and disposals |
132 |
154 |
–15 |
ROS in % |
11.7 |
12.8 |
– |
In 2007, total revenues of the Performance & Life Science Chemicals division increased by 1.5% to €1,235 million. Currency effects significantly impacted business in the United States and Asia: Organic growth was 4.7%. Gross margin increased slightly by 0.4% to €615 million. The operating result decreased by 7.0% to €144 million. This was affected by, among other things, the restructuring charges for measures in Switzerland and North America.
Return on sales was 11.7%. Free cash flow remained virtually constant at €132 million. The Performance & Life Science Chemicals division invested €58 million in research and development in 2007.
